SomnoMed Limited
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more
Market Cap & Net Worth: SomnoMed Limited (SOMNF)
SomnoMed Limited (PINK:SOMNF) has a market capitalization of $85.19 Million ($85.19 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #21840 globally and #7786 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SomnoMed Limited's stock price $0.39 by its total outstanding shares 218443253 (218.44 Million).
SomnoMed Limited Market Cap History: 2015 to 2025
SomnoMed Limited's market capitalization history from 2015 to 2025. Data shows change from $338.41 Million to $85.19 Million (-13.20% CAGR).
SomnoMed Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SomnoMed Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.76x
SomnoMed Limited's market cap is 0.76 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $504.19 Million | $44.08 Million | $165.00K | 11.44x | 3055.60x |
| 2017 | $500.43 Million | $49.33 Million | -$3.34 Million | 10.15x | N/A |
| 2018 | $204.42 Million | $52.39 Million | $2.32 Million | 3.90x | 88.23x |
| 2019 | $360.06 Million | $58.89 Million | -$39.39K | 6.11x | N/A |
| 2020 | $338.59 Million | $57.30 Million | -$1.12 Million | 5.91x | N/A |
| 2021 | $351.69 Million | $62.71 Million | -$1.19 Million | 5.61x | N/A |
| 2022 | $181.31 Million | $72.58 Million | -$4.44 Million | 2.50x | N/A |
| 2023 | $85.19 Million | $83.62 Million | -$8.00 Million | 1.02x | N/A |
| 2024 | $37.14 Million | $91.65 Million | -$12.24 Million | 0.41x | N/A |
| 2025 | $85.19 Million | $111.49 Million | -$3.46 Million | 0.76x | N/A |
Competitor Companies of SOMNF by Market Capitalization
Companies near SomnoMed Limited in the global market cap rankings as of March 18, 2026.
Key companies related to SomnoMed Limited by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
SomnoMed Limited Historical Marketcap From 2015 to 2025
Between 2015 and today, SomnoMed Limited's market cap moved from $338.41 Million to $ 85.19 Million, with a yearly change of -13.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $85.19 Million | +129.41% |
| 2024 | $37.14 Million | -56.41% |
| 2023 | $85.19 Million | -53.01% |
| 2022 | $181.31 Million | -48.45% |
| 2021 | $351.69 Million | +3.87% |
| 2020 | $338.59 Million | -5.96% |
| 2019 | $360.06 Million | +76.14% |
| 2018 | $204.42 Million | -59.15% |
| 2017 | $500.43 Million | -0.75% |
| 2016 | $504.19 Million | +48.99% |
| 2015 | $338.41 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SomnoMed Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $85.19 Million USD |
| MoneyControl | $85.19 Million USD |
| MarketWatch | $85.19 Million USD |
| marketcap.company | $85.19 Million USD |
| Reuters | $85.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.